Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review
Year of publication: |
2011
|
---|---|
Authors: | Shih, Ya-Chen T. ; Chien, Chun-Ru ; Xu, Ying ; Pan, I-Wen ; Smith, Grace L. ; Buchholz, Thomas A. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 29.2011, 4, p. 315-329
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Antineoplastics | therapeutic use | Bevacizumab | Cost-analysis | Cost-effectiveness | Renal-cell-carcinoma | treatment | Sorafenib | Sunitinib | Temsirolimus |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Economic Burden of Renal Cell Carcinoma in the US: Part II - An Updated Analysis
Shih, Ya-Chen T., (2011)
-
Zbrozek, Arthur S., (2010)
-
Cost Considerations in the Treatment of Colorectal Cancer
Jansman, Frank G.A., (2007)
- More ...
-
Economic Burden of Renal Cell Carcinoma in the US: Part II - An Updated Analysis
Shih, Ya-Chen T., (2011)
-
Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review
Smieliauskas, Fabrice, (2014)
-
Shih, Ya-Chen Tina., (2009)
- More ...